Benzinga | Nov 2, 2020 06:53AM EST

Eagle Pharmaceuticals Q3 EPS $1.17 Up From $0.26 YoY, Sales $49.93M Beat $47.02M Estimate

Eagle Pharmaceuticals (NASDAQ:EGRX) reported quarterly earnings of $1.17 per share. This is a 350 percent increase over earnings of $0.26 per share from the same period last year. The company reported quarterly sales of $49.93 million which beat the analyst consensus estimate of $47.02 million by 6.18 percent. This is a 21.34 percent increase over sales of $41.15 million the same period last year.